Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients

NCT: NCT05143164 · COMPLETED

NCT IDNCT05143164
StatusCOMPLETED
Start Date2022-03-11
Completion2025-12-30

Brief Summary

The study aims to examine the use of hydrocolloid dressing for catheter exit-site care in peritoneal dialysis patients. It is a pilot study, and participants will be randomized to either receiving weekly hydrocolloid dressing or daily topical gentamicin cream for exit-site care in peritoneal dialysis patients.

Frequently Asked Questions

What is Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients?

Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients is a clinical trial registered under NCT05143164. Current status: COMPLETED.

What is the status of NCT05143164?

The current status of NCT05143164 (Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients) is: COMPLETED.

When did Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients start?

Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients started on 2022-03-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑